Chemopurging of peripheral blood-derived progenitor cells by alkyl-lysophospholipid and its effect on haematopoietic rescue after high-dose therapy

Bone Marrow Transplantation

Volumn 18, Issue 3, 1996, Pages 549-557

  Koenigsmann, M P ^a,b   Notter, M ^a   Knauf, W U ^a   Papadimitriou, C A ^a   Oberberg, D ^a   Reufi, B ^a   Mucke C ^a   Thiel, E ^a   Berdel, W E ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Alkyl lysophospholipid; Autotransplantation; Chemopurging; Ether lipids; Haematopoietic rescue; Peripheral blood progenitor cells

Indexed keywords

ALKYLLYSOPHOSPHOLIPID; ANTINEOPLASTIC AGENT; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DEXAMETHASONE; DOXORUBICIN; EDELFOSINE; EPIRUBICIN; ETHER LIPID; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; MELPHALAN; MITOMYCIN; MITOXANTRONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA; VINCRISTINE;

ADULT; ARTICLE; AUTOTRANSPLANTATION; BLOOD TOXICITY; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT GM; CONTAMINATION; CRYOPRESERVATION; EWING SARCOMA; HEMATOPOIESIS; HODGKIN DISEASE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; MULTIPLE MYELOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; STOMACH CANCER; TESTIS CANCER; TUMOR CELL;

ADULT; AGED; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CRYOPRESERVATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; LYSOPHOSPHOLIPIDS; MIDDLE AGED; NEOPLASMS;

EID: 0029812269     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Juttner CA, To LB, Ho JQK et al. Early lympho-hematopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. Transplant Proc 1988; 20: 40-43.
2. Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 1991; 77: 211-213.
3. Sheridan WP, Begley CG, Juttner CA et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-644.
4. Liberti G, Pearce R, Taghipour G, Majolino I, Goldstone AH. Comparison of peripheral blood stem cells and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT Registry data. Lymphoma Working Party of the EBMT. Ann Oncol 1994; 5 (Suppl. 2): 151-153.
5. Gribben JG, Freedman AS, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. New Engl J Med 1991; 325: 1525-1533.
6. Uckun FM, Kersey JH, Haake R et al. Pretransplant burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia. New Engl J Med 1993; 329: 1296-1301.
7. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85-86.
8. Rill DR, Santana VM, Roberts WM et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 1994; 84: 380-383.
9. Bird JM, Bloxham D, Russell NH et al. Detection of clonally rearranged cells in PBSC harvests in multiple myeloma by immunoglobulin gene fingerprinting. Blood 1993; 82 (Suppl. 1): 265a (Abstr.).
10. Rizzoli V, Carlo-Stella C. Stem cell purging: an intriguing dilemma. Exp Hematol 1995; 23: 296-302.
11. Gorin NC, Aegerter P, Auvert B et al. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood 1990; 75: 1606-1614.
12. Andreesen R, Modolell M, Weltzien HU et al. Selective destruction of human leukemic cells by alkyl-lysophospholipids. Cancer Rex 1978; 38: 3894-3899.
13. Andreesen R, Modolell M, Munder PG. Selective sensitivity of chronic myelogenous leukemic cell populations to alkyl-lysophospholipids. Blood 1979; 54: 519-523.
14. Hoffman DR, Hoffman LH, Snyder F. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells. Cancer Res 1986; 46: 5803-5809.
15. Vogler WR, Olson AC, Okamoto S et al. Experimental studies on the role of alkyl lysophospholipids in autologous bone marrow transplantation. Lipids 1987; 22: 919-924.
16. Vogler WR, Berdel WE, Olson AC et al. Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid. Blood 1992; 80: 1423-1429.
17. Berdel WE, Okamoto S, Reichert A et al. Studies on the role of ether lipids as purging agents in autologous bone marrow transplantation. In: Kabara JJ (ed). The Pharmacological Effects of Lipids III. AOCS Press: Champaign, IL, 1990, pp 338-360.
18. Dietzfelbinger HF, Lang A, Oberberg D et al. Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells. Exp Hematol 1992; 20: 178-183.
19. Dietzfelbinger HF, Kühn D, Zafferani M et al. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation. Cancer Res 1993; 53: 3747-3751.
20. Notter M, Ludwig WD, Bremer S, Thiel E. Selective targeting of human lymphokine-activated killer cells by CD3 monoclonal antibody against the interferon-inducible high-affinity Fcγ RI receptor (CD64) on autologous acute myeloid leukemic blast cells. Blood 1993; 82: 3113-3124.
21. Schick HD, Berdel WE, Fromm M et al. Cytotoxic effects of ether lipids and derivatives in human non-neoplastic bone marrow cells and leukemic cells in vitro. Lipids 1987; 22: 904-910.
22. Siena S, Bregni M, Brando B. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400-409.
23. Fritsch G, Emminger W, Buchinger P et al. CD34-positive cell proportions in peripheral blood correlate with colony-forming capacity. Exp Hematol 1991; 19: 1079-1083.
24. + cells: correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony assay. Br J Haematol 1991; 77: 453-459.
25. Carlo-Stella C, Mangoni L, Almici C et al. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. Exp Hematol 1992; 20: 328-333.
26. Zimmer BM, Reufi B, Oberberg D et al. Generation of progenitor cell precursors in long-term bone marrow cultures after marrow purging with ether lipids. Int J Oncol 1995; 7: 1307-1313.
27. Laporte J Ph, Fouillard L, Douay L et al. GM-CSF instead of autologous bone marrow transplantation after the BEAM regimen. Lancet 1991; 338: 601-602.
28. Rowley SD, Zuehlsdorf M, Braine HG et al. CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow. Blood 1987; 70: 271-275.
29. Passos-Coelho JL, Braine HG, Davis JM et al. Predictive factors for peripheral blood progenitor cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol 1995; 13: 705-714.
30. Takamatsu Y, Harada M, Teshima T et al. Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation. Exp Hematol 1995; 23: 8-13.
31. Brugger W, Heimfeld S, Berenson RJ et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. New Engl J Med 1995; 333: 283-287.